Cargando…
Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020
BACKGROUND: Lyme disease (LD) is an infectious multi-system illness caused by the bacterial genus Borrelia and spread by bites of infected ticks. Although most patients are successfully treated by timely antibiotic therapy, it is broadly accepted that a sizeable number of patients experience treatme...
Autores principales: | DeLong, Allison, Hsu, Mayla, Kotsoris, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480773/ https://www.ncbi.nlm.nih.gov/pubmed/31014314 http://dx.doi.org/10.1186/s12889-019-6681-9 |
Ejemplares similares
-
Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020)
por: Geebelen, Laurence, et al.
Publicado: (2022) -
Corrigendum to “Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data”
por: Chung, Ming Kei, et al.
Publicado: (2023) -
A Reappraisal of the U.S. Clinical Trials of Post-Treatment Lyme Disease Syndrome
por: Fallon, Brian A, et al.
Publicado: (2012) -
Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease
por: Stricker, Raphael B, et al.
Publicado: (2011) -
Lyme Disease and Post-treatment Lyme Disease Syndrome: Current and Developing Treatment Options
por: Talbot, Norris C, et al.
Publicado: (2023)